First AD

Second AD

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Insights Video Series

Breast Cancer

ELI-22-OSD1261 - /clinical/colorectal-cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Optimizing Treatment for HR+/HER2- Breast Cancer: A Multidisciplinary Approach

Naomi Dempsey, MD, reviews data on the use of CDK4/6 inhibitors for the frontline treatment of metastatic HR+/HER- breast cancer.

Frontline CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer

Importance of Multidisciplinary Care for Patients With HR+/HER- Breast Cancer

Barriers to Optimal Care in Patients With HR+/HER- Breast Cancer

Clinical Scenario: A 60-Year-Old Woman With Newly Diagnosed Breast Cancer

Considerations for Chemotherapy Dosing in Patients With HR+/HER- Breast Cancer

Helping Patients With HR+/HER2- Breast Cancer Access Abemaciclib

Updates in Adjuvant Therapy for HR+/HER- Breast Cancer From ASCO 2023: The NATALEE Trial

Monitoring and Treating Lymphedema in Patients With HR+/HER- Breast Cancer

Considerations for Use of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer

Common Toxicities of CDK4/6 Inhibitors in Patients With HR+/HER2- Metastatic Breast Cancer

Utility of Primary Tumor Surgery for De Novo Metastatic Breast Cancer

Unmet Needs in the Treatment of HR+/HER2- Breast Cancer